Recent news coverage includes various industry and market developments but does not provide direct operational updates on Xsolla SPAC 1.

• Thyssenkrupp Nucera won a hydrogen project in Spain, indicating activity in the energy sector [N1].
• Natural gas prices gained following attacks on key energy infrastructure in Iran, affecting global energy markets [N2].
• CervoMed is preparing for multiple clinical milestones in 2026 while narrowing its cash runway [N3].
• HelloFresh reported a narrowed net loss for FY25 but warned on FY26 revenues and orders [N4].
• Ascendis Pharma announced positive Phase 2 trial results for TransCon HGH in Turner Syndrome [N5].
• KKR formed a $310 million partnership with PMI Electro to boost electric transport in India [N6].
• Hongkong and Shanghai Hotels swung to a profit in FY25 [N7].
• Frontera Energy reported a widened Q4 loss due to impairment charges and weak net sales [N8].

The company has successfully completed its IPO and private placement, securing $204 million in gross proceeds held in trust. This capital base provides the financial foundation to pursue a business combination. The company’s emerging growth status allows for certain regulatory flexibilities. The clear capital structure and warrant terms provide transparency to investors.

The company reported a net loss of $76,662 for the fiscal year ended December 31, 2025, and exhibits very low liquidity with a current ratio of 0.02, indicating potential challenges in meeting short-term obligations without the completion of a business combination. As a SPAC, there is inherent uncertainty regarding the timing and success of identifying and closing a suitable acquisition. No operational revenues or business activities are disclosed at this stage.

As a SPAC, Xsolla SPAC 1 does not have an operating business or competitive moat at this stage. Its value proposition lies in its ability to complete a business combination with a target company, leveraging capital raised from the IPO and private placement. The company’s moat will depend on the quality and strategic fit of the eventual acquisition target, which is not yet disclosed.

• Liquidity Risk: The company’s current ratio of 0.02 as of December 31, 2025, indicates very limited liquidity, which may constrain operational flexibility prior to a business combination.
• Business Combination Uncertainty: As a SPAC, the company’s future depends on successfully identifying and completing a business combination. Failure to do so within the prescribed timeframe could result in liquidation or loss of shareholder value.
• Emerging Growth Company Status: While providing regulatory relief, this status may also limit the amount of financial and operational disclosures available to investors, potentially increasing information asymmetry.

• Xsolla SPAC 1 is a Cayman Islands-incorporated special purpose acquisition company (SPAC).
• The company completed its initial public offering (IPO) on January 30, 2026, issuing 20,000,000 units at $10.00 per unit, raising gross proceeds of $200 million.
• Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at $11.50 per share.
• Simultaneously with the IPO, the company completed a private placement of 400,000 units to Xsolla SPAC I LLC at $10.00 per unit, raising $4 million.
• The company is listed on The Nasdaq Stock Market LLC under the ticker XSLL for Class A ordinary shares, XSLLU for units, and XSLLW for warrants.
• The company is classified as an emerging growth company under SEC rules.
• As of December 31, 2025, the company reported current assets of $4,673 and current liabilities of $274,682, resulting in a current ratio of 0.02, indicating very low liquidity.
• The company reported a net loss of $76,662 for the fiscal year ended December 31, 2025.
• There have been no material changes to the risk factors disclosed in the final prospectus for the IPO as of the latest quarterly report dated March 16, 2026.
• The net proceeds from the IPO and private placement were deposited in a trust account for the benefit of public shareholders as of January 28, 2026.